Trial intelligence / Profile preview

Local gentamicin in Redon-treated post-sternotomy mediastinitis

NL-OMON41174Phase 4Active, not recruiting

Sponsor
St. Antonius Ziekenhuis
Start
Mar 2015
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, open-label trial of gentamicin in mediastinitis and surgical site infection (SSI) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Hospital stay. Started Mar 2015; status: active, not recruiting.

02

Drugs

gentamicin
03

Conditions

mediastinitissurgical site infection (SSI)

Beyond the preview

Go deeper on NL-OMON41174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON41174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call